Cargando…
Possible discrepancy of HbA1c values and its assessment among patients with chronic renal failure, hemodialysis and other diseases
BACKGROUND: Glycated hemoglobin (HbA1c) and glycated albumin (GA) are frequently used as glycemic control markers. However, these markers are influenced by alterations in hemoglobin and albumin metabolism. Thus, conditions such as anemia, chronic renal failure, hypersplenism, chronic liver diseases,...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Japan
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4679780/ https://www.ncbi.nlm.nih.gov/pubmed/25824109 http://dx.doi.org/10.1007/s10157-015-1110-6 |
_version_ | 1782405581486686208 |
---|---|
author | Inoue, Kaori Goto, Atsushi Kishimoto, Miyako Tsujimoto, Tetsuro Yamamoto-Honda, Ritsuko Noto, Hiroshi Kajio, Hiroshi Terauchi, Yasuo Noda, Mitsuhiko |
author_facet | Inoue, Kaori Goto, Atsushi Kishimoto, Miyako Tsujimoto, Tetsuro Yamamoto-Honda, Ritsuko Noto, Hiroshi Kajio, Hiroshi Terauchi, Yasuo Noda, Mitsuhiko |
author_sort | Inoue, Kaori |
collection | PubMed |
description | BACKGROUND: Glycated hemoglobin (HbA1c) and glycated albumin (GA) are frequently used as glycemic control markers. However, these markers are influenced by alterations in hemoglobin and albumin metabolism. Thus, conditions such as anemia, chronic renal failure, hypersplenism, chronic liver diseases, hyperthyroidism, hypoalbuminemia, and pregnancy need to be considered when interpreting HbA1c or GA values. Using data from patients with normal albumin and hemoglobin metabolism, we previously established a linear regression equation describing the GA value versus the HbA1c value to calculate an extrapolated HbA1c (eHbA1c) value for the accurate evaluation of glycemic control. In this study, we investigated the difference between the measured HbA1c and the eHbA1c values for patients with various conditions. METHODS: Data sets for a total of 2461 occasions were obtained from 731 patients whose HbA1c and GA values were simultaneously measured. We excluded patients with missing data or changeable HbA1c levels, and patients who had received transfusions or steroids within the previous 3 months. Finally, we included 44 patients with chronic renal failure (CRF), 10 patients who were undergoing hemodialysis (HD), 7 patients with hematological malignancies and a hemoglobin level of less than 10 g/dL (HM), and 12 patients with chronic liver diseases (CLD). RESULTS: In all the groups, the eHbA1c values were significantly higher than the measured HbA1c values. The median difference was 0.75 % (95 % CI 0.40–1.10 %, P for the difference is <0.001) in the CRF group, 0.80 % (95 % CI 0.30–1.65 %, P for the difference is 0.041) in the HD group, 0.90 % (95 % CI 0.90–1.30 %, P for the difference is 0.028) in the HM group, and 0.85 % (95 % CI 0.40–1.50 %, P for the difference is 0.009) in the CLD group. CONCLUSIONS: We found that the measured HbA1c values were lower than the eHbA1c values in each of the groups. |
format | Online Article Text |
id | pubmed-4679780 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Springer Japan |
record_format | MEDLINE/PubMed |
spelling | pubmed-46797802015-12-22 Possible discrepancy of HbA1c values and its assessment among patients with chronic renal failure, hemodialysis and other diseases Inoue, Kaori Goto, Atsushi Kishimoto, Miyako Tsujimoto, Tetsuro Yamamoto-Honda, Ritsuko Noto, Hiroshi Kajio, Hiroshi Terauchi, Yasuo Noda, Mitsuhiko Clin Exp Nephrol Original Article BACKGROUND: Glycated hemoglobin (HbA1c) and glycated albumin (GA) are frequently used as glycemic control markers. However, these markers are influenced by alterations in hemoglobin and albumin metabolism. Thus, conditions such as anemia, chronic renal failure, hypersplenism, chronic liver diseases, hyperthyroidism, hypoalbuminemia, and pregnancy need to be considered when interpreting HbA1c or GA values. Using data from patients with normal albumin and hemoglobin metabolism, we previously established a linear regression equation describing the GA value versus the HbA1c value to calculate an extrapolated HbA1c (eHbA1c) value for the accurate evaluation of glycemic control. In this study, we investigated the difference between the measured HbA1c and the eHbA1c values for patients with various conditions. METHODS: Data sets for a total of 2461 occasions were obtained from 731 patients whose HbA1c and GA values were simultaneously measured. We excluded patients with missing data or changeable HbA1c levels, and patients who had received transfusions or steroids within the previous 3 months. Finally, we included 44 patients with chronic renal failure (CRF), 10 patients who were undergoing hemodialysis (HD), 7 patients with hematological malignancies and a hemoglobin level of less than 10 g/dL (HM), and 12 patients with chronic liver diseases (CLD). RESULTS: In all the groups, the eHbA1c values were significantly higher than the measured HbA1c values. The median difference was 0.75 % (95 % CI 0.40–1.10 %, P for the difference is <0.001) in the CRF group, 0.80 % (95 % CI 0.30–1.65 %, P for the difference is 0.041) in the HD group, 0.90 % (95 % CI 0.90–1.30 %, P for the difference is 0.028) in the HM group, and 0.85 % (95 % CI 0.40–1.50 %, P for the difference is 0.009) in the CLD group. CONCLUSIONS: We found that the measured HbA1c values were lower than the eHbA1c values in each of the groups. Springer Japan 2015-04-01 2015 /pmc/articles/PMC4679780/ /pubmed/25824109 http://dx.doi.org/10.1007/s10157-015-1110-6 Text en © The Author(s) 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Original Article Inoue, Kaori Goto, Atsushi Kishimoto, Miyako Tsujimoto, Tetsuro Yamamoto-Honda, Ritsuko Noto, Hiroshi Kajio, Hiroshi Terauchi, Yasuo Noda, Mitsuhiko Possible discrepancy of HbA1c values and its assessment among patients with chronic renal failure, hemodialysis and other diseases |
title | Possible discrepancy of HbA1c values and its assessment among patients with chronic renal failure, hemodialysis and other diseases |
title_full | Possible discrepancy of HbA1c values and its assessment among patients with chronic renal failure, hemodialysis and other diseases |
title_fullStr | Possible discrepancy of HbA1c values and its assessment among patients with chronic renal failure, hemodialysis and other diseases |
title_full_unstemmed | Possible discrepancy of HbA1c values and its assessment among patients with chronic renal failure, hemodialysis and other diseases |
title_short | Possible discrepancy of HbA1c values and its assessment among patients with chronic renal failure, hemodialysis and other diseases |
title_sort | possible discrepancy of hba1c values and its assessment among patients with chronic renal failure, hemodialysis and other diseases |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4679780/ https://www.ncbi.nlm.nih.gov/pubmed/25824109 http://dx.doi.org/10.1007/s10157-015-1110-6 |
work_keys_str_mv | AT inouekaori possiblediscrepancyofhba1cvaluesanditsassessmentamongpatientswithchronicrenalfailurehemodialysisandotherdiseases AT gotoatsushi possiblediscrepancyofhba1cvaluesanditsassessmentamongpatientswithchronicrenalfailurehemodialysisandotherdiseases AT kishimotomiyako possiblediscrepancyofhba1cvaluesanditsassessmentamongpatientswithchronicrenalfailurehemodialysisandotherdiseases AT tsujimototetsuro possiblediscrepancyofhba1cvaluesanditsassessmentamongpatientswithchronicrenalfailurehemodialysisandotherdiseases AT yamamotohondaritsuko possiblediscrepancyofhba1cvaluesanditsassessmentamongpatientswithchronicrenalfailurehemodialysisandotherdiseases AT notohiroshi possiblediscrepancyofhba1cvaluesanditsassessmentamongpatientswithchronicrenalfailurehemodialysisandotherdiseases AT kajiohiroshi possiblediscrepancyofhba1cvaluesanditsassessmentamongpatientswithchronicrenalfailurehemodialysisandotherdiseases AT terauchiyasuo possiblediscrepancyofhba1cvaluesanditsassessmentamongpatientswithchronicrenalfailurehemodialysisandotherdiseases AT nodamitsuhiko possiblediscrepancyofhba1cvaluesanditsassessmentamongpatientswithchronicrenalfailurehemodialysisandotherdiseases |